Premier Sponsors
View By:
April 8-9
Display of Antibodies
Antibodies for Cancer Therapy
Improving Immunotherapy Efficacy and Safety
Difficult-to-Express Proteins
Characterization of Biotherapeutics
Immunogenicity Case Studies and Clinical Management
Fusion Protein Therapeutics
Emerging Indications for Therapeutic Antibodies
April 10 - 11
Engineering Antibodies
Advancing Bispecific Antibodies and Combination Therapy to the Clinic
CAR Ts, TCRs and TILs
Optimizing Protein Expression
Biophysical and Structural Analysis
Immunogenicity Assessment and Regulatory Approval of Biologics
Engineering Antibody-Drug Conjugates
Oncolytic Viral Therapy
April 11 - 12
Engineering Bispecific Antibodies
Clinical Progress of Antibody-Drug Conjugates
Agonist Immunotherapy Targets
Protein Expression System Engineering
Analytical Support for Drug Product Development
Optimizing Bioassays for Biologics